St Pharm Co., Ltd. (237690)

Overview

ST Pharm Co. Ltd. functions as a contract development manufacturing organization headquartered in Seoul, South Korea, offering a comprehensive range of services across both pharmaceutical and non-pharmaceutical sectors. Originally established as Samchully Pharmaceutical Company., Ltd. in 1983, the company has pivoted and expanded its offerings to meet the evolving needs of its clients. ST Pharm is distinguished for its Chemistry Manufacturing Control (CMC) services, which play a crucial role in ensuring the quality and compliance of pharmaceutical products. Through its dedication to innovation and quality, ST Pharm has established itself as a key player in the pharmaceutical manufacturing industry, catering to a diverse array of therapeutic areas and technological needs.

Products and Services

• Chemistry Manufacturing Control (CMC) Services

  ST Pharm offers a comprehensive suite of CMC services to support the development and regulatory approval process of pharmaceutical products. This includes analytical method development, in-house reference standard testing, analytical method qualification/validation, analytical characterization, and CMC documentation, ensuring thorough quality assurance at every stage of product development.

• Oligonucleotide Based Products

  The company specializes in the development and manufacturing of oligonucleotide products, encompassing a variety of molecules such as antisense, siRNA, miRNA, aptamer, CpG, decoy, and more. These products have applications in gene therapy and molecular diagnostics, showcasing ST Pharm’s commitment to cutting-edge biotechnological research and therapy development.

• Monomer/Phosphoramidite

  As part of its oligonucleotide production capabilities, ST Pharm produces monomer and phosphoramidite components, which are essential for synthesizing oligonucleotides. This positions the company as a key supplier in the oligonucleotide synthesis supply chain, facilitating the broader availability of these important biochemical tools.

• Generic Active Pharmaceutical Ingredients (APIs)

  ST Pharm manufactures a wide range of generic APIs targeting numerous therapeutic areas such as anti-cancer, anti-coagulant, anti-fungal, anti-hyperlipidemia, anti-hypertensive, anti-tuberculosis, asthma, COPD (Chronic Obstructive Pulmonary Disease), cough suppressant, diabetes mellitus, epilepsy, hepatitis B, and erectile dysfunction, as well as MRI contrast agents. This broad spectrum of APIs underscores the company’s versatility and capability in addressing global healthcare needs.

• Non-Pharmaceutical Products

  Beyond its pharmaceutical ventures, ST Pharm engages in the production of secondary battery materials, electronic materials, and polymer catalysts. This diversification into non-pharmaceutical areas highlights the company’s technical expertise and innovative approach to leveraging chemical manufacturing processes across different industrial applications.